The scanning of maturing mRNAs by ribosomes plays a key role in the mRNA quality control process. When ribosomes first engage with the newly synthesized mRNA, and if peptides are produced, is unclear, however. Here we show that ribosomal scanning of prespliced mRNAs occurs in the nuclear compartment, and that this event produces peptide substrates for the MHC class I pathway. Inserting antigenic peptide sequences in introns that are spliced out before the mRNAs exit the nuclear compartment results in an equal amount of antigenic peptide products as when the peptides are encoded from the main open reading frame (ORF). Taken together with the detection of intron-encoded nascent peptides and RPS6/RPL7-carrying complexes in the perinucleolar compartment, these results show that peptides are produced by a translation event occurring before mRNA splicing. This suggests that ribosomes occupy and scan mRNAs early in the mRNA maturation process, and suggests a physiological role for nuclear mRNA translation, and also helps explain how the immune system tolerates peptides derived from tissue-specific mRNA splice variants. 
The scanning of maturing mRNAs by ribosomes plays a key role in the mRNA quality control process. When ribosomes first engage with the newly synthesized mRNA, and if peptides are produced, is unclear, however. Here we show that ribosomal scanning of prespliced mRNAs occurs in the nuclear compartment, and that this event produces peptide substrates for the MHC class I pathway. Inserting antigenic peptide sequences in introns that are spliced out before the mRNAs exit the nuclear compartment results in an equal amount of antigenic peptide products as when the peptides are encoded from the main open reading frame (ORF). Taken together with the detection of intron-encoded nascent peptides and RPS6/RPL7-carrying complexes in the perinucleolar compartment, these results show that peptides are produced by a translation event occurring before mRNA splicing. This suggests that ribosomes occupy and scan mRNAs early in the mRNA maturation process, and suggests a physiological role for nuclear mRNA translation, and also helps explain how the immune system tolerates peptides derived from tissue-specific mRNA splice variants.
MHC class I restricted antigen presentation | mRNA maturation | nuclear translation R NAs carrying premature termination codons or are recognized as defective in other aspects are prevented from further translation and disposed of by the nonsense-mediated decay (NMD) pathway (1) . The detection of premature stop codons is mediated by the scanning ribosome; however, when the ribosomes first engage with the newly synthesized mRNA, and if this event results in the production of peptides, is unclear. Two observations from the field of immunology and the presentation of peptides on MHC class I molecules have highlighted some aspects relevant to the role of the ribosomes in the mRNA maturation process. The first observation is related to the detection of antigenic peptides originating from intron sequences, and the second is related to the observation that the synthesis of antigenic peptide substrates and full-length proteins are two spatiotemporarily distinct events (2) (3) (4) (5) .
The presentation of antigenic peptides on MHC class I molecules allows CD8
+ T cells to detect and eliminate cells in which the repertoire of peptide substrates has been altered owing to the presence of viruses or to changes in the presentation of endogenous antigens (6, 7) . However, despite the key role of antigen presentation on MHC class I molecules in immune surveillance, the source of peptides for the MHC class I pathway is not yet known. Accumulating evidence indicates that the processing of alternative peptide substrates plays a major role, and that degradation products derived from full-length proteins have limited access to the MHC class I pathway (8) (9) (10) . We recently demonstrated that pioneer translation products (PTPs) that form antigenic peptide substrates for the MHC class I pathway are produced by a translation event that is distinct from the canonical event giving rise to full-length proteins and does not require the cap-binding translation factor eIF4E, and also that mRNAs that have stopped producing peptides substrates for the MHC class I pathway still produce full-length proteins (8) .
Here we report that antigenic peptides for the MHC class I pathway are synthesized during an early steps in the mRNA maturation process by a noncanonical translation mechanism within the nuclear compartment and before introns are spliced out.
Results and Discussion Subcellular Localization of Intron and Exon RNA Sequences. The detection of peptides on MHC class I molecules is highly sensitive, with only a few peptide-MHC class I complexes required to activate specific T cells, and thus can serve to detect rare peptide products derived from noncanonical translation during the mRNA maturation process (8) . We aimed to take advantage of this property to identify the early ribosomal scanning event that give rise to peptide products. To do so, we introduced two different antigenic peptide sequences presented on the K b [SIINFEKL (SL8) epitope from chicken ovalbumin] (11) and the K k [MBP (79-87) epitope from myelin basic protein (MBP)] (12) MHC class I molecules in the exon or intron sequences of mRNAs encoding the β-Globin gene (Fig. 1A and Fig. S1A ). We also introduced premature termination codons (PTCs; Glob-intron/ exon-PTCs) to provoke NMD and prevent the synthesis of fulllength proteins from the mRNAs (1, 13).
Significance
The major histocompatibility complex (MHC) class I antigen presentation pathway allows the immune system to distinguish between self and non-self. Despite extensive research on the processing of antigenic peptides, little is still known about their origin. We recently proposed that a unique class of peptides, termed pioneer translation products (PTPs), is produced during the pioneer rounds of mRNA translation and provides the major source of antigenic peptide substrates for direct presentation to the MHC class I pathway. Here we show that a major portion of the substrates for the MHC class I pathway is synthesized during the early steps of mRNA maturation via a noncanonical translation mechanism within the nucleus and before introns are spliced out. RNA FISH using probes toward the intron sequences, the exon sequences, or both sequences demonstrated the presence of exons from the Glob-exon-SL8 mRNA in the nuclear and cytoplasmic compartments, whereas introns from the same construct were detected in the nucleus only. Introduction of a PTC codon (Glob-exon-SL8-PTC) resulted in a sharp decrease in the amount of exons detected in the cytoplasm (Fig. 1B and Fig. S2 ). Fractionation of cellular compartments followed by RT-PCR confirmed that intron sequences were removed before the RNA was exported to the cytoplasm, and that the introduction of PTC codons targeted the mRNAs for the NMD pathway (Fig. 1C) . Western blot analysis demonstrated that the presence of the PTC prevents synthesis of the full-length Globin protein from the Globexon-SL8-PTC and Glob-intron-SL8-PTC mRNAs (Fig. 1D) . Thus, the positioning of antigenic peptide-encoding sequences within introns and/or in the context of PTCs prevents the peptides from being synthesized by the canonical translation machinery that governs cap-dependent synthesis of full-length proteins in the cytoplasm.
Ribosomal Scanning of Nonspliced mRNAs Gives Rise to Production of
Antigenic Peptides for the MHC Class I Pathway. We introduced the foregoing constructs in HEK293 Kb cells that stably express the Kb class I molecule, and then used the B3Z T-cell hybridoma (14) that specifically detects the SL8 epitope presented on Kb molecules to determine the relative amount of antigenic peptides derived from the different mRNA constructs. Increasing the amount of respective cDNA resulted in a gradual increase in antigen presentation from all constructs irrespective of whether or not the SL8 epitope was located in the intron or the exon sequence or whether the mRNA was targeted for the NMD pathway ( Fig. 2A) . showing the Glob-exon-SL8RNA in the nuclear and cytoplasmic compartments. Exon probes alone (Upper Right and Lower Right) detected the presence of exon RNA sequences in the cytoplasm and nucleus. The introduction of a PTC resulted in loss of exon staining in the cytoplasm (Lower Right). Intron-specific probes (Lower Left) detected RNA in the nuclear compartment only (Fig. S2 ). (C) Subcellular fractionation followed by RT-PCR using exon-junction primers showing that the introduction of a PTC codon triggers NMD and depletes mRNA levels in both the nuclear and cytoplasmic compartments (Fig. S3A ). The graph shows the average of three experiments with Glob-exon-SL8 mRNA levels set to 100%. (D) Western blot showing that the presence of the PTC prevents canonical mRNA translation and the synthesis of full-length proteins. Kb cells followed by incubation with the SL8-specific CD8 + T-cell hybridoma (B3Z) revealed the production of the SL8 epitope derived from PTPs irrespective of whether the epitope was introduced in the intron or exon sequence or whether the mRNAs carry a PTC.
(B) Introducing the SL8 epitope in either the distal region of intron 1 or intron 2 led to an ∼40% reduction in antigen presentation compared with that in the proximal region of intron 1 or in exon 1. (C) Changing the SL8 epitope for the MBP epitope presented on K k MHC class I molecules and detected by specific CD8 + T cells showed a similar profile as the SL8 epitope.
(D) A single nucleotide frame shift inserted before the SL8 epitope resulted in an ∼100-fold reduction in antigen presentation. The data show the average of at least three independent experiments with SD minus the values from mock-transfected cells. Free SL8 peptide was added to cells to ensure that T-cell assays were carried out at nonsaturated conditions and that the expression of MHC class I molecules was not affected.
To ensure that production of the SL8 peptide when inserted in the first intron sequence was not related to missplicing that would retain the first intron in the spliced mRNA, we also introduced the SL8 epitope in the second intron (Glob-intron2-SL8). The presentation of SL8 was observed from the second intron, but at an ∼40% lower level compared with the first intron.
The presentation of antigenic peptides depends on proteolytic processing and hence on the amino acids surrounding the epitope; thus, moving an epitope within an RNA can alter its processing. In line with this notion, we observed a similar 40% reduction in antigen presentation when we moved the SL8 from the proximal region to the distal region of the first intron (Globintron1-distal-SL8) (Fig. 2B) .
The RNA sequence surrounding the epitope might possibly play a role in governing noncanonical initiation of the antigenic peptide substrate. This idea is consistent with the observation that introducing a silent point mutation in codon 39 (CUC to CUG) upstream of the MBP(79-87) epitope in the MBP mRNA led to a 30% increase in antigen presentation (8) . Exchanging the SL8 peptide for the MBP peptide and using a T-cell hybridoma specific for this epitope (15) resulted in a similar production of antigenic peptide substrates from intron and exon sequences, demonstrating that presentation of epitopes derived from introns is not restricted to the epitope or to a certain class I molecule (Fig. 2C) . Interestingly, the relative levels of SL8 vs.
MBP presentation differed depending on the context in which they were synthesized, further suggesting that the location and context of the antigenic peptide within the mRNA is important to substrate production and peptide processing.
Finally, we placed the SL8 epitope in a different ORF by introducing a single nucleotide upstream of the antigenic peptideencoding sequence (Glob-out-exon-SL8), and found an ∼100-fold decrease in antigen presentation ( Fig. 2D and Fig. S1A ). These results show that the synthesis of antigenic peptide substrates occurs on nonspliced mRNAs and depends on whether or not the epitope is in frame with the initiation codon of the main ORF. This supports the idea that the scanning of prespliced mRNAs by a noncanonical translation event produces PTPs that form an important source of antigenic peptide substrates for the MHC class I pathway.
Interfering with mRNA Nuclear Export Increases Production of MHC Class I Substrates. Introns were spliced out before the mRNA exited the nucleus, indicating that the production of peptide material occurs before the RNAs are exported out of the nucleus. To further test whether peptide epitopes inserted in introns are indeed translated in the nucleus, we introduced the Rev responsive element (RRE) of the HIV RNA in the 3′ UTR of the Glob-exon/intron-SL8 constructs (16, 17) (Fig.  S1A ). This sequence targets nonspliced and spliced mRNAs (Fig. S3D) .
for Rev-dependent nuclear export through the CRM1 pathway (18) . Using either RNA FISH on fixed cells or RT-PCR on subcellular fractions, we detected the presence of introns in the cytoplasm after overexpression of Rev (Fig. 3A and Fig. S3A ). Introduction of increasing amounts of Rev in cells expressing a fixed amount of the Glob-exon/intron-SL8-RRE resulted in a dose-dependent decrease in mRNA levels in the nucleus, accompanied by decreased presentation of the SL8 epitope on the Kb molecules ( Fig. 3B and Fig.  S3B ). In contrast, prevention of Rev-dependent nuclear export of the Glob-exon/intron-SL8-RRE mRNAs using the CRM1 inhibitor leptomycin B (LMB) (19) resulted in increased antigen presentation (Fig. 3C and Fig. S3C ).
We further tested the correlation between mRNA export and antigen presentation by inserting the SL8 epitope in the IFN-α1 mRNA, which is exported through the CRM1 but does not bind the Rev protein (20) . In this situation, Rev instead blocks IFN-α1 mRNA export by interfering with the CRM1, resulting in increased SL8 peptide production (Fig. 3D) . In further support of prespliced mRNAs as a source for antigenic peptide substrates, we observed an increase in antigen presentation when the splicing machinery was inhibited using the isoginkgetin compound (21, 22) (Fig. 3E and Fig. S3D ). These results may shed further light on the finding that PTC codons can be detected while the nascent RNA is still linked to the RNA polymerase (23). The compound puromycin is incorporated in the nascent peptide and, together with the elongation inhibitor emetine, can be used to visualize nascent peptides attached to the ribosome using anti-puromycin antibodies (27) . Expression of the HA epitope from within an intron (Glob-intron-HA-PTC), followed by fixation and anti-puromycin (mouse mAb) and anti-HA (rabbit polyclonal sera) shows colocalization in the nucleus but not in the cytoplasm. (C) The PLA allows identification of two primary antibodies in close proximity. Secondary PLA-labeled antibodies revealed a specific signal toward anti-puromycin and anti-HA antibodies in the nuclear and cytoplasmic compartments from the Glob-exon-HA construct (Upper) and in the nuclear compartment using Glob-intron-HA-PTC (Lower). (D) (Left) Immunohistochemistry detected S6 of the small ribosomal subunit in the cytoplasm, nucleoli, and perinucleoli. (Center) The combination of anti-HA and anti-S6 showed a nuclear PLA reaction only. (Right) Anti-S6 (mouse Ab) and anti-L7 of the large subunit (polyclonal Ab) showed PLA complexes in the cytoplasmic and nuclear compartments. The S6 and L7 PLA complexes were not detected in nucleoli despite the large amount of respective proteins in this compartment (Fig. S4D) .
Detection of PTPs on the Nascent Ribosome in the Nuclear Compartment.
We next inserted the HA tag next to the antigenic epitope to visualize PTPs derived from introns or from mRNAs targeted for the NMD pathway using immunohistochemistry. We observed a specific signal in the nucleus of cells expressing the Globintron-HA-PTC constructs using anti-HA antibodies (Fig. 4A) . Application of 15-and 30-min pulses with the proteasome inhibitor epoxomycin resulted in increased detection of HAcarrying peptides in the nucleus accompanied by detection in the cytoplasm as well. This indicates a short half-life of PTPs, which is in line with the first model to predict alternative translation products, or defective ribosomal products (DRiPs) as the source of peptides for the MHC class I pathway (10, 24) .
The presentation of PTPs for the class I pathway requires proteasomal activity, and the rapid degradation of these substrates ensures their prompt availability for the immune system, and also minimizes the potential risk of PTPs interfering with other cellular processes. Translational profiling and mass spectrometry (MS) studies have recently identified a large pool of noncanonical small translation products in mammalian cells initiated from non-AUG codons and from intron sequences (25, 26) . After insertion of the 6xHis-tag after the SL8 epitope in the Glob-exon-SL8-PTC construct (Glob-exon/intron-SL8-His-PTC) (Fig. S1A) and enrichment of His-tagged PTP products through nickel agarose affinity chromatography, MS analysis detected a series of peptides of various lengths carrying the SL8 epitope derived from both intron and exon sequences ( Table 1 and  Table S1 ).
The puromycin compound is incorporated into the nascent peptide by the ribosome and, together with the elongation inhibitor emetine and an anti-puromycin antibody, can be used to detect nascent peptides on the polysome (27, 28) . Incubation of cells expressing the Glob-intron-HA-PTC construct with these two compounds, followed by fixation and anti-HA-tag (rabbit Ab) and anti-puromcyin (mouse Ab) antibodies, revealed colocalization between HA and puromycin in the nuclear compartment (Fig. 4B) . We did not observe such colocalization in the cytoplasm, presumably because the majority of HA-carrying epitopes in this compartment are not linked to polysomes (Fig. S4A) .
To determine whether the HA tag is present on nascent PTPs, we used proximal ligation assay (PLA)-labeled secondary antibodies, which allows detection of two primary antibodies in close proximity (29) . The combination of PLA-labeled anti-HA and anti-puromycin antibodies and the use of saponin to permeabilize cells produced a specific signal in the nuclear and cytoplasmic compartments of cells expressing the Glob-exon-HA construct. Expression of the Glob-intron-HA-PTC gave rise to a nuclear PLA signal, however, demonstrating the presence of the nascent HA epitope derived from an intron sequence in the nuclear compartment (Fig. 4C) . Estimating the amount of nascent PTPs using this approach is difficult, given the potential destruction of some HA epitopes by puromycin and relatively short lengths of the PTPs. However, anti-HA alone under these conditions produced no PLA reaction, and no positive signals were detected in nontransfected cells (Fig. S4B) .
The majority of the S6 ribosomal protein is detected in the cytoplasm and nucleoli, with a small fraction detected in the perinucleoli (Fig. 4D, Left and Fig. S4C ). We carried out PLA-based colocalization using anti-HA and anti-RPS6 antibodies and, interestingly, detected colocalization in the nucleus but not in the nucleoli (Fig. 4D, Center) . Similar to RPS6, we detected the majority of L7 of the large subunit in the cytoplasm and in the nucleoli, as expected, but also a small but significant amount in the perinucleoli (Fig. S4D) . Using a combination of anti-RPS6 and anti-RPL7 antibodies, we detected PLA complexes in the cytoplasm and the nucleus. Importantly, we did not detect the nuclear RPS6-RPL7 PLA complexes in the nucleoli, even though the majority of RPS6 and RPL7 were present in this compartment (Fig. 4D, Right) . Taken together, these results suggest that the production of PTPs occurs in the nucleus, but outside the nucleoli.
Concluding Remarks
Nuclear translation has been a controversial issue. Previous reports have suggested that nuclear translation indeed can occur (27, (30) (31) (32) , but the physiological context has remained obscure. Our data presented here indicate that a major portion of the substrates for the MHC class I pathway are synthesized in the early steps of mRNA maturation by a noncanonical translation mechanism within the nucleus and before introns are spliced out. Thus, the ribosomes engage with the newly synthesized mRNA earlier than previously thought. This translation event ensures that the first peptides derived from an mRNA are presented to the MHC class I pathway, allowing early immune detection of infected cells. CD8 + T cells toward epitopes derived from introns have been identified previously (2, 5) , and our results provide an explanation for these observations. The production of PTPs from nonspliced RNAs in thymic cells would guarantee that peptides derived from all possible splice variants of hnRNAs are presented during T-cell selection, and thereby safeguard against the possibility that alternative tissue-specific splicing events in peripheral tissues could give rise to autoimmune reactions. In fact, the production of antigenic peptides from prespliced mRNAs could be a prerequisite for allowing tissue-dependent splicing to occur.
Our results open up new possibilities for investigating the production of antigenic peptides that will have implications for generating vaccines, understanding dysfunctional antigen presentation in disease, and developing novel immune therapies, including those against cancer cells. It also sheds light on a unique mRNA translation event and raises the possibility that different ribosomes produce peptide products with different functions, similar to how different RNA polymerases produce different classes of RNAs, each with a defined function. Amino acids in bold type are encoded by the first intron sequence of the β-Globin gene. A complete list of peptides is provided in Table S1 .
Materials and Methods
RNA Preparation, RT-PCR, and qRT-PCR. For nuclear/cytoplasmic RNA extraction, HEK-293 cells were plated in six-well plates and transfected with the indicated constructs. At 48 h posttransfection, cells were washed with cold PBS and then resuspended in 120 μL of LB buffer [10 mM NaCl, 2 mM MgCl 2 , 10 mM Tris·HCl (pH 7.8), 5 mM DTT, 0.5% Nonidet P-40, and 3 μL/mL RNaseOUT). Samples were placed on ice for 5 min and then centrifuged at 6000 × g for 5 min at 4°C. The cytoplasmic fraction was collected and transferred to a new microcentrifuge tube, and 120 μL of ProtK buffer [0.2 M Tris·HCl (pH 7.5), 25 mM EDTA, 0.3 M NaCl, 2% SDS, and 3 μL/mL RNaseOUT] was added. After the addition of 20 μL of Proteinase K (10 mg/mL) and incubation of samples at 37°C for 20 min, cytoplasmic RNA was purified using the RNeasy Mini Kit (Qiagen) following the manufacturer's protocol and on-column DNase treatment (RNeasy, Quiagen).
The nuclear RNA pellet was resuspended in 120 μL of LB buffer, after which 120 μL of ProtK buffer and 20 μL of proteinase K were added, and the nuclear fractions were incubated at 37°C for 20 min. Nuclear RNA was purified with the RNeasy Mini Kit (Qiagen). Reverse transcription was carried out as described previously (8) . Primers are listed in SI Materials and Methods.
Peptide Purification, Peptide Digestion, MS Analysis, and Peptide Identification. Transfected HEK293 kb cells were lysed in 6 mL of 6 M guanidinium HCl, 0.1 M Na 2 HPO 4 /NaH 2 PO 4 , 0.01 M Tris·HCl (pH 8.0), 5 mM imidazole, and 10 mM β-mercaptoethanol, and then sonicated on ice for 20 s three times. Then 75 μL of Ni 2+ -NTA agarose beads (Qiagen) were added, and lysates were rotated at room temperature for 6 h. Beads were then washed for 10 min with 800 μL of 6 M guanidinium HCl, 0.1 M Na 2 HPO 4 /NaH 2 PO 4 , 0.01 M Tris·HCl (pH 8.0), and 10 mM β-mercaptoethanol; 6 M urea, 0.1 M Na 2 HPO 4 / NaH 2 PO 4 , 0.01 M Tris·HCl (pH 8.0) and 10 mM β-mercaptoethanol; 6 M urea, 0.1 M Na 2 HPO 4 /NaH 2 PO 4 , 0.01 M Tris·HCl (pH 6.8), 10 mM β-mercaptoethanol (buffer A) plus 0.2% Triton X-100; buffer A again; and then buffer A plus 0.1% Triton X-100. After the last wash, His-6-tagged peptides were eluted by incubating the beads in 80 μL of 200 mM imidazole, 0.15 M Tris·HCl (pH 6.7), 30% glycerol, and 0.72 M β-mercaptoethanol for 30 min at room temperature. Peptides were then digested with trypsin before analysis by LC-MS/MS as described previously (33) .
Tandem MS data were searched against the UniProt database and the translated sequence from the Glob-SL8-PTC-His construct, without enzyme specificity. Database searches and false-discovery rate estimation were performed using the EasyProt software platform (33) . Only peptide spectra matches with a false-discovery rate <1% were retained.
Cell Fixation and Immunostaining. Cells were plated on 24 × 24 mm coverslips in six-well plates or on 12-mm-diameter coverslips in 24-well plates. At 24 h posttransfection, the cells were washed briefly with cold PBS and then fixed in 4% PFA for 10 min at room temperature, rinsed twice with PBS 1×, and saturated with PBS, 3% BSA, and 0.1% saponin (saturation buffer) for 30 min. Primary antibodies (see below) were incubated for 2 h at room temperature or overnight at 4°C, and secondary antibodies were incubated for 30 min at room temperature, both in saturation buffer. The anti-nucleolin antibody (Abcam) and anti-Globin antibody (Sigma-Aldrich) were mouse Abs.
Proximal Ligation Assay. HEK cells were grown on coverslips and transfected with indicated constructs for 48 h and treated with 500 nM epoxomicin (Peptanova) for 15 min, 208 μM emetine (Sigma-Aldrich) for 5 min, and then 91 μM puromycin (Sigma-Aldrich) for 3 min. The cells were fixed in 4% paraformaldehyde for 15 min before being permeabilized in PBS and 3% BSA containing 0.1% saponin. Primary antibodies-mouse anti-puromycin (a kind gift from Alexandre David, Institut de Génomique Fonctionnelle, Montpellier, France), mouse anti-S6 (Cell Signaling), rabbit polyclonal anti-L7 (Cell Signaling), rabbit polyclonal anti-HA (Sigma-Aldrich), or mouse anti-HA (a kind gift from Borek Vojtesek, Masaryk Memorial Cancer Institute, Brno, Czech Republic)-were incubated in the same buffer for 2 h. After the cells were washed, PLA probes were added, followed by hybridization, ligation, and amplification according to the manufacturer's protocol (Olink Bioscience). Coverslips were mounted on slides using Duolink in situ mounting medium (OLink Bioscience) with DAPI. Slides were analyzed by fluorescence microscopy.
